PaxMedica
patient population autism clinical trial | PaxMedica
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
18 of 24
Related slides by other companies
Palantir
Results
November 2020
a top pharmaceutical company is linking data from more than clinical trials in foundry to uncover trends across trials and securely analyze outcomes at a population level | Palantir
GH Research
Investor Presentation
March 2023
phase clinical pharmacology trial in healthy volunteers completed | GH Research
Cytek
Investor Day
June 2022
clinical flow normal cell populations cancer cell populations galler | Cytek
Recursion Pharmaceuticals
Investor Day
January 2023
clinical finalize design of a phase enriched trial initiate phase trial in select tumor types in early identify suitable partners for genetic testing capabilities evaluate in combination with targeted and or immune modulating agents next steps | Recursion Pharmaceuticals
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights